FDA instructs Amgen to pull Enbrel ads

02/22/2005 | NYTimes.com

The FDA ordered Amgen to pull its television ads for Enbrel, indicated for psoriasis, on grounds the advertisement did not disclose risks or mention the drug was indicated only for "chronic moderate to severe plaque psoriasis," and not milder forms. The agency also told the company its ad overstated Enbrel's effectiveness. An Amgen spokeswoman said the ad has been pulled and the company is reviewing the letter.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL